somatostatin

Further investigations about somatostatin in this field could also be of interest.

There are six somatostatin genes that have been discovered in vertebrates.

Somatostatin and a long acting analogue, octreotide, have received particular attention recently.

These drugs can also be used as an adjunct to somatostatin analogue therapy.

Somatostatin and octreotide also have an effect on bile composition.

Somatostatin has a major inhibitory effect, including on pancreatic juice production.

Octreotide (a somatostatin analogue) can be used to help symptoms.

Somatostatin analogues are also sometimes used to shrink large tumors before surgery.

Interferon treatment is also effective, and usually combined with somatostatin analogues.

And when this happens, somatomedins lower the level of growth hormone by stimulating somatostatin.

Finally, it also inhibits somatostatin release from D cells.

Shortly after the man began taking the synthetic somatostatin, his tongue had shrunk to half its previous size, he said.

He even diagrammed the chemical structure of somatostatin.

The radioactive drug attaches to tumor cells that have receptors for somatostatin.

All of the somatostatin related proteins are involved in the inhibition of hormones.

Levels of the neurotransmitters serotonin, norepinephrine, and somatostatin are also often reduced.

Octreotide is a synthetic modifications of somatostatin with a longer half-life.

These cells contain the peptides (small proteins), substance P and somatostatin (among others).

The effect of somatostatin on the human sphincter of Oddi has not been established.

A small amount of a radioactive drug similar to somatostatin is injected into a vein and travels through the bloodstream.

Unlike somatostatin, when infused into the brain, it enhances slow-wave sleep.

The rostral region aids in the production of both somatostatin and thyroid releasing hormone.

The role of somatostatin, infused at a rate of 250 g/h, in our patient remains thus hypothetical.

A long-acting somatostatin analogue that can be given as an injection once a month, with equivalent efficacy, is now available.

When somatomedin levels are high, they reduce growth hormone levels by stimulating somatostatin production.